Ivermectin for Alpaca: Deworming Uses, Mange Treatment & Safety

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Ivermectin is a prescription antiparasitic medication in the macrocyclic lactone family. Your vet may use it in alpacas to help control certain internal parasites and some external parasites, especially mites involved in mange. In camelids in the United States, drug use is generally extra-label, which means the medication is used under veterinary direction rather than under an alpaca-specific FDA label.

In practical terms, ivermectin is not a one-size-fits-all dewormer. It can be useful in the right case, but it does not cover every parasite and it is not always the best first choice for every herd problem. Parasite control in alpacas works best when your vet matches treatment to fecal testing, body condition, age, pasture pressure, and local parasite patterns.

Ivermectin is available in several formulations in other species, including injectable and oral products. In alpacas, your vet chooses the route and schedule based on the problem being treated, the animal's weight, and food-animal considerations such as residue avoidance and withdrawal guidance.

Your vet may use ivermectin in alpacas for selected gastrointestinal and respiratory parasites, and it is also commonly discussed in camelid parasite-control programs. Merck lists ivermectin among drugs used in llamas and alpacas, and also lists an oral 0.2 mg/kg dose for lungworms in alpacas and llamas. Cornell also notes that camelid services commonly include parasite monitoring and control, which is important because treatment decisions should be based on the herd's real parasite burden rather than routine calendar dosing.

Another common use is mange treatment. Merck's camelid herd-health guidance notes that all four major mange mite groups have been diagnosed in camelids and that many cases respond to routine parenteral ivermectin doses repeated every 10 to 14 days. Mange can cause intense itch, crusting, hair loss, weight loss, and skin damage, so early veterinary care matters.

Ivermectin may also be part of some prevention programs for meningeal worm exposure in regions where that parasite is a concern. Still, no single dewormer should be treated as a complete parasite plan. Your vet may recommend fecal egg counts, skin scrapings, pasture management, and sometimes a different dewormer if resistance or poor coverage is a concern.

Always use ivermectin only under your vet's direction. In Merck's table of selected drugs used in llamas and alpacas, ivermectin is listed at 0.2-0.4 mg/kg SC or IM, repeated in 10 days. Merck also lists 0.2 mg/kg by mouth for lungworms in alpacas and llamas. For mange, Merck's camelid guidance says many cases respond to routine parenteral doses repeated every 10-14 days.

That does not mean every alpaca should receive the same dose or schedule. The right plan depends on the target parasite, body weight, pregnancy or lactation status, herd history, and whether your vet is treating one alpaca or building a whole-herd control plan. Underdosing can fail to clear parasites and may contribute to resistance. Overdosing raises the risk of neurologic side effects.

Your vet may also adjust the route. Injectable products are often used for mange protocols in camelids, while oral dosing may be chosen for some internal parasites. Because alpacas are considered food animals in the US, your vet also has to consider residue avoidance. Withdrawal guidance can vary by formulation and use pattern, so pet parents raising fiber or breeding animals should ask for exact instructions in writing.

Many alpacas tolerate ivermectin well when it is dosed correctly, but side effects are still possible. Mild problems can include injection-site soreness, temporary lethargy, or reduced appetite. If the medication is being used because of a heavy parasite burden, some alpacas may also seem tired or uncomfortable as they recover, which is one reason follow-up matters.

More serious reactions are usually neurologic and need urgent veterinary attention. Across animal species, ivermectin toxicity can cause ataxia, weakness, depression, tremors, vision changes, and in severe cases collapse or breathing problems. These signs are more likely with dosing errors, concentrated livestock products used incorrectly, or accidental repeat dosing.

See your vet immediately if your alpaca becomes wobbly, unusually dull, unable to rise, stops eating, or seems to have sudden vision or breathing changes after treatment. If mange is being treated, also contact your vet if the skin becomes more inflamed, painful, or infected, because the alpaca may need additional skin care rather than more dewormer alone.

Ivermectin should not be combined casually with other medications. Drugs in the same broad parasite-control family, such as other macrocyclic lactones, may increase the risk of overdose if products are layered without a clear veterinary plan. This can happen when herd treatments, pour-ons, injectables, and oral products are all being used on the farm at the same time.

Your vet should also know about any sedatives, anti-inflammatory drugs, antibiotics, supplements, or recent dewormers your alpaca has received. While published camelid-specific interaction data are limited, ivermectin is a drug where formulation, route, and timing matter. That is especially true in young, thin, debilitated, or pregnant animals.

One more safety point is food-animal status. Because alpacas are treated as food animals in the US and most camelid drug use is extra-label, your vet may need to consult residue-avoidance guidance before combining ivermectin with other medications. You can ask your vet whether any recent treatments change the timing, route, or withdrawal recommendations for ivermectin in your alpaca.